Ricardo Nitrini Selected Research

Amyloidosis

7/2016

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo Nitrini Research Topics

Disease

37	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2003
20	Cognitive Dysfunction 01/2022 - 09/2003
15	Dementia (Dementias) 01/2021 - 09/2003
5	Inflammation (Inflammations) 11/2021 - 04/2013
4	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2013
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 04/2013
3	COVID-19 02/2021 - 01/2020
3	Gliosis 01/2021 - 10/2019
3	Neoplasms (Cancer) 11/2018 - 02/2014
3	Infections 01/2016 - 09/2015
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014 - 04/2008
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 07/2013 - 06/2002
2	Corticobasal Degeneration 04/2021 - 01/2021
2	Temporal Lobe Epilepsy 01/2021 - 10/2004
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 12/2018
2	Disease Progression 01/2021 - 04/2014
2	Hypertension (High Blood Pressure) 11/2020 - 11/2017
2	Autoimmune Diseases of the Nervous System 11/2018 - 10/2016
2	Encephalitis (Encephalitis, Rasmussen) 10/2016 - 02/2014
2	Edema (Dropsy) 09/2015 - 04/2013
2	Stroke (Strokes) 01/2009 - 06/2006
2	Neurosyphilis (General Paresis of the Insane) 03/2006 - 07/2005
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Paralysis (Palsy) 10/2021
1	Parkinsonian Disorders (Parkinsonism) 10/2021
1	Synkinesis 04/2021
1	Brain Diseases (Brain Disorder) 02/2021
1	Neuroinflammatory Diseases 01/2021
1	Amyloid Plaque 01/2021
1	Normal Pressure Hydrocephalus 04/2019
1	Wounds and Injuries (Trauma) 07/2017
1	Diabetes Mellitus 01/2017
1	Seizures (Absence Seizure) 11/2016
1	Amyloidosis 07/2016
1	Periodontitis 01/2016
1	Leukoencephalopathies 09/2015
1	Chorea (Rheumatic Chorea) 08/2015
1	Sleep Wake Disorders 08/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2015
1	Hydrocephalus (Hydrocephaly) 01/2015
1	Cysticercosis 01/2015
1	Neurocysticercosis 01/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2014
1	Mixed Dementias 06/2014
1	Nervous System Paraneoplastic Syndromes 02/2014

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
9	Amyloid (Amyloid Fibrils)IBA 11/2021 - 07/2005
5	amsonic acid (DAS)IBA 01/2021 - 12/2003
5	AntibodiesIBA 11/2018 - 02/2014
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 09/2008
3	Apolipoproteins E (ApoE)IBA 01/2017 - 01/2008
3	Prion ProteinsIBA 07/2013 - 10/2004
3	Codon (Codons)IBA 07/2013 - 10/2004
2	Amyloid beta-PeptidesIBA 01/2022 - 03/2019
2	Biological ProductsIBA 01/2022 - 01/2020
2	AntigensIBA 01/2020 - 10/2016
2	CytokinesIBA 01/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 04/2015 - 01/2015
2	Indicators and Reagents (Reagents)IBA 05/2014 - 03/2014
2	tau Proteins (tau Protein)IBA 07/2005 - 09/2004
1	C-Reactive ProteinIBA 01/2022
1	chemotactic factor inactivatorIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Levodopa (L Dopa)FDA LinkGeneric 10/2021
1	InterleukinsIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	Pharmaceutical PreparationsIBA 11/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	ParaffinIBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Caspase 3 (Caspase-3)IBA 10/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2018
1	Antihypertensive Agents (Antihypertensives)IBA 11/2017
1	SuspensionsIBA 07/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2016
1	ProgranulinsIBA 10/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Aquaporins (Water Channels)IBA 09/2015
1	Insulin (Novolin)FDA Link 04/2015
1	Insulin-Like PeptidesIBA 04/2015
1	Histamine Antagonists (Antihistamines)IBA 01/2015
1	dexchlorpheniramine (dexchlorpheniramine maleate)FDA Link 01/2015
1	Nimodipine (Modus)FDA LinkGeneric 06/2014
1	Galantamine (Galanthamine)FDA LinkGeneric 06/2014
1	salicylhydroxamic acid (SHAM)IBA 03/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2014
1	SteroidsIBA 02/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2014

Therapy/Procedure

5	Activities of Daily Living (ADL) 03/2015 - 04/2008
5	Therapeutics 04/2014 - 06/2002
3	Immunotherapy 11/2021 - 02/2014
2	Aftercare (After-Treatment) 11/2021 - 06/2006
1	Ventriculoperitoneal Shunt 04/2019
1	Plasmapheresis 02/2014